C12N 2770/24351
Methods of production or purification of viral material
C12N2770/24351 (Methods of production or purification of viral material) appears on 13 US grants and 18 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 18
- Assignees
- 13
- Inventors
- 41
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 2 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 1 |
| 2019 | 2 | 1 |
| 2020 | 0 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 3 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Adjuvant compositions13 Jan 2026US 12,521,433 B2Zoetis Services LLC
- Compositions and methods for internal controls of microvesicle isolations25 Mar 2025US 12,258,587 B2Exosome Diagnostics, Inc.
- Adjuvant compositions13 Feb 2024US 11,896,666 B2Zoetis Services LLC
- Recombinant vector comprising BiP fragment and preparation method of recombinant proteins using thereof6 Sep 2022US 11,434,496 B2Bioapplications Inc.
- Adjuvant compositions9 Mar 2021US 10,940,202 B2Zoetis Services LLC
- Recombinant classical swine fever virus e2 protein with b/c domain swapping17 Jul 2025US 2025/0230194 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Novel Adjuvant Compositions31 Oct 2024US 2024/0358825 A1Zoetis Services LLC
- Recombinant classical swine fever virus e2 protein24 Oct 2024US 2024/0350610 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Mammalian cell line and method for producing soluble e2 recombinant antigen of classical swine fever virus using the same and application thereof27 Jun 2024US 2024/0209033 A1National Pingtung University of Science and Technology
- Compositions and methods for internal controls of microvesicle isolations30 Dec 2021US 2021/0403881 A1Exosome Diagnostics, Inc.
Most cited
By later US patents
- Adjuvant compositions17US 9,662,385 B2Zoetis Services LLC · 2017
- Adjuvant compositions15US 8,580,280 B2Zoetis LLC · 2013
- Adjuvant compositions6US 10,238,736 B2Zoetis Services LLC · 2019
- Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method4US 9,322,024 B2Korea University Research and Business Foundation · 2016
- Adjuvant compositions2US 11,896,666 B2Zoetis Services LLC · 2024